Insider Shareholders with Direct Ownership of Coherus Bio Sciences, Inc. (CHRS)
This section provides a comprehensive overview of the insiders with direct ownership of Coherus Bio Sciences, Inc. (CHRS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Coherus BioSciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dennis M Lanfear
President & CEO |
803,494 | 288,058 | 708,694 $524,433 | 10 |
Jan 20, 2024
Reduced 1.56%
|
|
Vincent R Anicetti
Chief Operating Officer |
246,597 | 171,751 | 124,790 $92,344 | 24 |
Jul 06, 2021
Added 28.61%
|
|
Vladimir Vexler
Chief Scientific Officer |
281,356 | 225,568 | 116,361 $86,107 | 18 |
Mar 31, 2023
Reduced 12.27%
|
| 99,988 | 99,988 | 99,988 $73,991 | 4 |
Feb 01, 2024
Added 31.03%
|
|
|
Paul Reider
Chief Commercial Officer |
0 | 11,629 | 81,277 $60,144 | 4 |
Jan 20, 2024
Reduced 5.64%
|
|
Mc David Stilwell
Chief Financial Officer |
103,700 | 34,299 | 75,305 $55,725 | 9 |
Dec 31, 2023
Reduced 19.67%
|
|
Jean Frederic Viret
Chief Financial Officer |
80,152 | 65,765 | 61,295 $45,358 | 9 |
Feb 01, 2021
Reduced 10.77%
|
|
Bryan J Mc Michael
Chief Financial Officer |
12,500 | 5,113 | 22,972 $16,999 | 4 |
Jan 20, 2024
Reduced 6.92%
|